Modeling fusion gene-associated sarcoma using the ex vivo gene transfer technique succeeded in generating the NTRK3 fusion sarcoma model and provided useful information for molecular targeted therapy as a preclinical model, though improvement of the method is needed for more efficient tumor induction. Here, NTRK3 is linked to sarcoma.